Search Results 1081-1090 of 17896 for Assay

1. Study of bb2121 in Multiple Myeloma - Clinical Trials

   Serum free light chain (FLC) assay: involved FLC level greater or equal to 10 mg/dL (100 mg/L) provided serum FLC ratio is abnormal. For Part A (Dose ...

2. Aplastic anemia - Diagnosis & treatment - Mayo Clinic

   Your body stops producing enough new blood cells in this rare and serious condition, possibly causing fatigue, higher risk of infections and uncontrolled ...

3. Publications - Qun Lu, M.D. - Mayo Clinic

   Performance of an automated solid-phase red cell adherence system compared with that of a manual gel microcolumn assay for the identification of antibodies ...

4. Phase Transitions: Ph.D. Students Explore Real-Time Seizure Detection and Antibiotic Resistance - News Archive

   While assays exist to detect and identify the presence of microbes, the tests can be negative, making it challenging to determine if a patient has an infection.

5. A Phase 1b/2 Study of Onvansertib (PCM-075) in Combination with FOLFIRI and Bevacizumab for Second-Line Treatment of Metastatic Colorectal Cancer in Patients with a KRAS Mutation - Mayo Clinic

   ... assays. Submission of the tissue does not have to occur prior to enrollment. Signed informed consent to provide blood sample(s) for specific correlative assays.

6. Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair - Mayo Clinic

   ... assay are not eligible to participate unless they also have MMR testing by IHC and are found to have dMMR (i.e. loss of one or more MMR proteins); Patients ...

7. A Study to Evaluate Lenalidomide and Dexamethasone, with or without Daratumumab, in Treating High-Risk Smoldering Myeloma Patients - Mayo Clinic

   Abnormal serum free light chain (FLC) ratio of involved to uninvolved >20, but less than 100 if the involved FLC is >10 mg/dL by serum FLC assay;; Serum M ...

8. Clinical trials - Urology

   ... assayed from blood of cases with CAP and controls without history of cancer. A Study of Advanced Magnetic Resonance Imaging of the Prostate/Pelvis using ...

9. Efficacy and Safety of Treatment With Alpelisib Plus Endocrine Therapy in Patients With HR+, HER2-negative aBC, With PIK3CA Mutations, Whose Disease Has Progressed on or After CDK 4/6 Treatment With an Aromatase Inhibitor (AI) or Fulvestrant - Mayo Clinic

   Patient has a pathology report confirming PIK3CA mutant status by a certified laboratory using a validated PIK3CA mutation assay (either from tissue or blood).

10. Publications - Jiasen Ma, Ph.D. - Mayo Clinic

    Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 2016; 12 (1):1-222. View PubMed; Chang FM, Ma J, Pan Z ...